Pfizer Clinical Trial Acknowledged By IBC Committee
Trusted by teams at
Description
The committee acknowledged an ongoing Pfizer-sponsored clinical trial using the Shionogi RSV Protocol v2.0 to evaluate S-337395 in high-risk adults with RSV. Contractual or funding specifics are not detailed in the minutes.
Contract Details
Vendor
PFIZER
Agency
University Of Massachusetts Medical School Worcester, MA
Contract Type
OTHER
Document Date
March 19, 2026
Renewal Info
No information is provided on trial timelines, contract renewals, or extension options for the Pfizer-sponsored study.
More from PFIZER
Issuing Agency
Higher Ed
Worcester, MA
More from University Of Massachusetts Medical School Worcester
Get alerts on contract renewals, new awards, and vendor activity.
B2G and SLED sales intelligence. Surface government procurement signals from 80,000+ state, local, and education agencies months before the RFP.